Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

PFE

Pfizer (PFE)

Pfizer Inc
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:PFE
DateHeureSourceTitreSymboleSociété
16/05/202417h55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PFEPfizer Inc
16/05/202413h27IH Market NewsChubb Stock Soars 9% with Berkshire Acquisition, AST SpaceMobile jumps 37% on AT&T deal, and More NewsNYSE:PFEPfizer Inc
16/05/202412h00GlobeNewswire Inc.Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®)NYSE:PFEPfizer Inc
13/05/202414h00PR Newswire (US)Astellas Showcases Scientific Advancements Across its Oncology Portfolio at 2024 ASCO Annual MeetingNYSE:PFEPfizer Inc
13/05/202413h16IH Market NewsArm Sets 2025 Target for AI Chip Development, Amazon and Microsoft Commit Billions to French Investments, and MoreNYSE:PFEPfizer Inc
09/05/202415h01Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:PFEPfizer Inc
09/05/202413h53IH Market NewsBain Capital in Talks to Acquire PowerSchool; Blackstone Emerges Victorious in Hipgnosis Bidding War, and More NewsNYSE:PFEPfizer Inc
08/05/202421h56Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:PFEPfizer Inc
06/05/202412h45Business WirePfizer Announces New Chief Strategy and Innovation OfficerNYSE:PFEPfizer Inc
01/05/202415h12IH Market NewsCVS Health, Starbucks, Shares Weaker; Pinterest SoarsNYSE:PFEPfizer Inc
01/05/202412h45Business WirePfizer Reports First-Quarter 2024 ResultsNYSE:PFEPfizer Inc
30/04/202400h40Business WireTIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical CancerNYSE:PFEPfizer Inc
30/04/202400h40Business WireFDA Grants Full Approval for TIVDAK® to Treat Recurrent or Metastatic Cervical CancerNYSE:PFEPfizer Inc
29/04/202412h45Business WirePfizer Highlights Progress in Accelerating Breakthrough Cancer Medicines at ASCO 2024 Annual MeetingNYSE:PFEPfizer Inc
26/04/202413h48IH Market NewsAnglo American Rejects BHP Group’s Offer, Toyota Invests $1.4 Billion in Indiana, and More NewsNYSE:PFEPfizer Inc
26/04/202412h45Business WireU.S. FDA Approves Pfizer’s BEQVEZ™ (fidanacogene elaparvovec-dzkt), a One-Time Gene Therapy for Adults with Hemophilia BNYSE:PFEPfizer Inc
24/04/202422h37Business WirePfizer Declares Second-Quarter 2024 DividendNYSE:PFEPfizer Inc
24/04/202413h28IH Market NewsCoca-Cola and Microsoft Sign Billion-Dollar Agreement, Apple Event Set for May 7, and More NewsNYSE:PFEPfizer Inc
22/04/202414h08Business WireEuropean Commission Approves Pfizer’s EMBLAVEO® for Patients with Multidrug-Resistant Infections and Limited Treatment OptionsNYSE:PFEPfizer Inc
11/04/202416h00Business WirePfizer Invites Shareholders to Attend Virtual-Only 2024 Annual Meeting of Shareholders on April 25NYSE:PFEPfizer Inc
10/04/202413h13IH Market NewsDelta Generates US$37 Million Profit in Q1, Google and Intel Unveil Cutting-Edge AI Chips, and More NewsNYSE:PFEPfizer Inc
09/04/202412h45Business WirePfizer Announces Positive Top-Line Results from Phase 3 Study of ABRYSVO® in Adults Aged 18 to 59 at Increased Risk for RSV DiseaseNYSE:PFEPfizer Inc
08/04/202418h44PR Newswire (US)ALTIVIA Appoints Scott Barnum as Director of Manufacturing and Dean Hale as Corporate Engineering ManagerNYSE:PFEPfizer Inc
26/03/202412h20IH Market NewsSuper Micro Computer and Seagate Shares Surge on Analyst Optimism in Pre-Market Trading, and Latest NewsNYSE:PFEPfizer Inc
21/03/202412h17IH Market NewsApple Pre-Market Drop Due to Antitrust Threats, Surprising Profit Boosts Micron Shares, and Latest Market UpdatesNYSE:PFEPfizer Inc
20/03/202415h00Business WirePfizer Invites Public to View and Listen to Webcast of May 1 Conference Call with AnalystsNYSE:PFEPfizer Inc
19/03/202412h33IH Market NewsUnilever Initiates Ice Cream Division Spin-Off and Announces Job Cuts; Berkshire Ramps Up Share Buyback Efforts, and MoreNYSE:PFEPfizer Inc
18/03/202412h10IH Market NewsApple & Google in Talks for Gemini AI on iPhone, Nvidia’s GTC Conference Today, and Latest NewsNYSE:PFEPfizer Inc
13/03/202409h00Business WireEuropean Commission Approves Pfizer’s PREVENAR 20® to Help Protect Infants and Children Against Pneumococcal DiseaseNYSE:PFEPfizer Inc
12/03/202411h45Business WirePfizer Announces Positive Overall Survival in Phase 3 Trial of ADCETRIS® Regimen in Patients with Relapsed/​Refractory Diffuse Large B-cell Lymphoma (DLBCL)NYSE:PFEPfizer Inc
 Showing the most relevant articles for your search:NYSE:PFE

Dernières Valeurs Consultées

Delayed Upgrade Clock